DELTA FINANCIAL ADVISORS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1790295
Metairie, LA
Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$881,062
-$234,630 QoQ
Shares Held
1,413
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#669
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DELTA FINANCIAL ADVISORS LLC holds $1,309,739 across 2 Biotechnology names. REGN ranks #1 (67.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,413 | $881,062 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
863 | $428,677 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $881,062 | 1,413 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,115,692 | 1,444 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,121,527 | 1,453 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $831,035 | 1,478 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $754,425 | 1,437 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $902,509 | 1,423 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $963,782 | 1,353 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,424,430 | 1,355 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,466,186 | 1,395 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,342,673 | 1,395 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,212,040 | 1,380 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,053,388 | 1,280 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $919,731 | 1,280 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,080,496 | 1,315 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $977,618 | 1,355 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $933,418 | 1,355 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $803,936 | 1,360 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $949,851 | 1,360 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $855,709 | 1,355 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $816,993 | 1,350 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $759,614 | 1,360 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $605,146 | 1,279 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $576,350 | 1,193 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $609,040 | 1,088 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $656,703 | 1,053 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $484,871 | 993 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||